Inactive Instrument
Guided Therapeutics Inc Share Price OTC Bulletin Board
Stocks
US40171F2048
Advanced Medical Equipment & Technology
OTC Markets Traded|
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 15/07 | Guided Therapeutics, Inc. Announces New Agreement With Yuanshuo Medical Instruments Corporation | CI |
| 16/06 | Guided Therapeutics Files Premarket Approval Application Clinical Report with FDA | CI |
| Market Cap | 2.8Cr 2.42Cr 2.26Cr 2.08Cr 3.92Cr 266.2Cr 3.97Cr 27Cr 10Cr 133.19Cr 11Cr 10Cr 441.13Cr | P/E 2024 |
-3x | P/E 2025 | -12.7x |
|---|---|---|---|---|---|
| Enterprise Value | 3.09Cr 2.67Cr 2.49Cr 2.29Cr 4.33Cr 293.55Cr 4.38Cr 29Cr 11Cr 146.88Cr 12Cr 11Cr 486.45Cr | EV / Sales 2024 |
1,649x | EV / Sales 2025 | 64.4x |
| Free-Float |
63.48% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Mark Faupel
CEO | Chief Executive Officer | 70 | 06/03/2023 |
| Chief Tech/Sci/R&D Officer | 70 | 02/12/2010 |
| Director | Title | Age | Since |
|---|---|---|---|
John Imhoff
BRD | Director/Board Member | 76 | 10/04/2006 |
Richard Blumberg
BRD | Director/Board Member | 69 | 10/11/2016 |
Mark Faupel
BRD | Director/Board Member | 70 | 01/12/2016 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +2.32% | +0.24% | +23.89% | +4.72% | 21TCr | ||
| +2.51% | +1.61% | +0.31% | -21.89% | 14TCr | ||
| +1.88% | +6.26% | -21.34% | +21.33% | 13TCr | ||
| -2.75% | +3.69% | -54.46% | -5.89% | 7.11TCr | ||
| -0.70% | +3.74% | +12.28% | +11.44% | 5.16TCr | ||
| +0.62% | +9.24% | -15.14% | -20.39% | 5TCr | ||
| +1.37% | +0.58% | +22.82% | +11.54% | 3.93TCr | ||
| +0.99% | +5.41% | +42.25% | +38.06% | 3.89TCr | ||
| +0.40% | +4.55% | -21.39% | +20.01% | 3.22TCr | ||
| Average | +0.79% | +3.19% | -1.20% | +6.55% | 8.43TCr | |
| Weighted average by Cap. | +1.28% | +1.42% | +0.14% | +3.28% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 7T 6.06T 5.65T 5.2T 9.81T 7L 9.92T 66.41T 26.07T 3L 26.29T 25.71T 11.03L | 8L 7L 6L 6L 10.75L 7.29Cr 10.87L 72.77L 28.56L 3.65Cr 28.81L 28.17L 12Cr |
| Net income | -24.17L -20.93L -19.51L -17.95L -33.88L -23Cr -34.26L -2.29Cr -90L -11Cr -90.78L -88.78L -38Cr | -31.96L -27.68L -25.8L -23.73L -44.8L -30Cr -45.3L -3.03Cr -1.19Cr -15Cr -1.2Cr -1.17Cr -50Cr |
| Net Debt | 17.71L 15.34L 14.3L 13.15L 24.83L 17Cr 25.1L 1.68Cr 65.95L 8.43Cr 66.52L 65.05L 28Cr | 28.76L 24.91L 23.22L 21.36L 40.32L 27Cr 40.77L 2.73Cr 1.07Cr 14Cr 1.08Cr 1.06Cr 45Cr |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
















